A detailed history of Forefront Analytics, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Forefront Analytics, LLC holds 16,103 shares of ANNX stock, worth $121,899. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,103
Previous 14,818 8.67%
Holding current value
$121,899
Previous $106,000 26.42%
% of portfolio
0.04%
Previous 0.05%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $5,564 - $8,725
1,285 Added 8.67%
16,103 $78,000
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $66,341 - $128,568
-16,462 Reduced 52.63%
14,818 $106,000
Q4 2023

Feb 13, 2024

SELL
$1.63 - $4.63 $652 - $1,852
-400 Reduced 1.26%
31,280 $142,000
Q3 2023

Nov 07, 2023

BUY
$2.13 - $3.84 $10,415 - $18,777
4,890 Added 18.25%
31,680 $74,000
Q2 2023

Aug 11, 2023

BUY
$2.1 - $6.37 $24,231 - $73,503
11,539 Added 75.66%
26,790 $94,000
Q1 2023

May 11, 2023

SELL
$3.74 - $7.46 $766 - $1,529
-205 Reduced 1.33%
15,251 $58,000
Q4 2022

Feb 13, 2023

SELL
$4.56 - $6.61 $2,731 - $3,959
-599 Reduced 3.73%
15,456 $79,000
Q3 2022

Nov 14, 2022

SELL
$3.75 - $6.63 $18,112 - $32,022
-4,830 Reduced 23.13%
16,055 $98,000
Q2 2022

Aug 10, 2022

SELL
$2.11 - $4.06 $2,954 - $5,683
-1,400 Reduced 6.28%
20,885 $77,000
Q1 2022

May 09, 2022

BUY
$2.73 - $11.94 $60,838 - $266,082
22,285 New
22,285 $63,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $360M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.